These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 35063895)

  • 1. Exploratory studies on soluble small molecule CD4 mimics as HIV entry inhibitors.
    Tsuji K; Kobayakawa T; Konno K; Masuda A; Takahashi K; Ohashi N; Yoshimura K; Kuwata T; Matsushita S; Harada S; Tamamura H
    Bioorg Med Chem; 2022 Feb; 56():116616. PubMed ID: 35063895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small-Molecule CD4 Mimics Containing Mono-cyclohexyl Moieties as HIV Entry Inhibitors.
    Ohashi N; Harada S; Mizuguchi T; Irahara Y; Yamada Y; Kotani M; Nomura W; Matsushita S; Yoshimura K; Tamamura H
    ChemMedChem; 2016 Apr; 11(8):940-6. PubMed ID: 26891461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble-type small-molecule CD4 mimics as HIV entry inhibitors.
    Kobayakawa T; Konno K; Ohashi N; Takahashi K; Masuda A; Yoshimura K; Harada S; Tamamura H
    Bioorg Med Chem Lett; 2019 Mar; 29(5):719-723. PubMed ID: 30665681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and antiviral activity of a series of CD4-mimetic small-molecule HIV-1 entry inhibitors.
    Curreli F; Ahmed S; Benedict Victor SM; Iusupov IR; Spiridonov EA; Belov DS; Altieri A; Kurkin AV; Debnath AK
    Bioorg Med Chem; 2021 Feb; 32():116000. PubMed ID: 33461144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flexibility of small molecular CD4 mimics as HIV entry inhibitors.
    Kobayakawa T; Ohashi N; Hirota Y; Takahashi K; Yamada Y; Narumi T; Yoshimura K; Matsushita S; Harada S; Tamamura H
    Bioorg Med Chem; 2018 Nov; 26(21):5664-5671. PubMed ID: 30366786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Discovery and Development of Oxalamide and Pyrrole Small Molecule Inhibitors of gp120 and HIV Entry - A Review.
    Motati DR; Uredi D; Watkins EB
    Curr Top Med Chem; 2019; 19(18):1650-1675. PubMed ID: 31424369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, Synthesis, and Antiviral activity of 1,2,3,4-Tetrahydropyrimidine derivatives acting as novel entry inhibitors to target at "Phe43 cavity" of HIV-1 gp120.
    Senapathi J; Bommakanti A; Kusuma V; Vangara S; Kondapi AK
    Bioorg Med Chem; 2021 Dec; 52():116526. PubMed ID: 34839157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41.
    Lu L; Yu F; Cai L; Debnath AK; Jiang S
    Curr Top Med Chem; 2016; 16(10):1074-90. PubMed ID: 26324044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hybrids of Small-Molecule CD4 Mimics with Polyethylene Glycol Units as HIV Entry Inhibitors.
    Kobayakawa T; Tsuji K; Konno K; Himeno A; Masuda A; Yang T; Takahashi K; Ishida Y; Ohashi N; Kuwata T; Matsumoto K; Yoshimura K; Sakawaki H; Miura T; Harada S; Matsushita S; Tamamura H
    J Med Chem; 2021 Feb; 64(3):1481-1496. PubMed ID: 33497209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent Progress in the Development of HIV-1 Entry Inhibitors: From Small Molecules to Potent Anti-HIV Agents.
    Suttisintong K; Kaewchangwat N; Thanayupong E; Nerungsi C; Srikun O; Pungpo P
    Curr Top Med Chem; 2019; 19(18):1599-1620. PubMed ID: 31424370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4 mimics as HIV entry inhibitors: lead optimization studies of the aromatic substituents.
    Narumi T; Arai H; Yoshimura K; Harada S; Hirota Y; Ohashi N; Hashimoto C; Nomura W; Matsushita S; Tamamura H
    Bioorg Med Chem; 2013 May; 21(9):2518-26. PubMed ID: 23535561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based design, synthesis and validation of CD4-mimetic small molecule inhibitors of HIV-1 entry: conversion of a viral entry agonist to an antagonist.
    Courter JR; Madani N; Sodroski J; Schön A; Freire E; Kwong PD; Hendrickson WA; Chaiken IM; LaLonde JM; Smith AB
    Acc Chem Res; 2014 Apr; 47(4):1228-37. PubMed ID: 24502450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2-Aminothiazolones as anti-HIV agents that act as gp120-CD4 inhibitors.
    Tiberi M; Tintori C; Ceresola ER; Fazi R; Zamperini C; Calandro P; Franchi L; Selvaraj M; Botta L; Sampaolo M; Saita D; Ferrarese R; Clementi M; Canducci F; Botta M
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3043-52. PubMed ID: 24614386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and evaluation of small molecule CD4-mimics as entry inhibitors possessing broad spectrum anti-HIV-1 activity.
    Curreli F; Belov DS; Ramesh RR; Patel N; Altieri A; Kurkin AV; Debnath AK
    Bioorg Med Chem; 2016 Nov; 24(22):5988-6003. PubMed ID: 27707628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD4 mimics targeting the mechanism of HIV entry.
    Yamada Y; Ochiai C; Yoshimura K; Tanaka T; Ohashi N; Narumi T; Nomura W; Harada S; Matsushita S; Tamamura H
    Bioorg Med Chem Lett; 2010 Jan; 20(1):354-8. PubMed ID: 19926478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyvalent side chain peptide-synthetic polymer conjugates as HIV-1 entry inhibitors.
    Danial M; Root MJ; Klok HA
    Biomacromolecules; 2012 May; 13(5):1438-47. PubMed ID: 22455441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitors of HIV-1 attachment. Part 3: A preliminary survey of the effect of structural variation of the benzamide moiety on antiviral activity.
    Meanwell NA; Wallace OB; Wang H; Deshpande M; Pearce BC; Trehan A; Yeung KS; Qiu Z; Wright JJ; Robinson BA; Gong YF; Wang HG; Spicer TP; Blair WS; Shi PY; Lin PF
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5136-9. PubMed ID: 19632112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule fusion inhibitors: design, synthesis and biological evaluation of (Z)-3-(5-(3-benzyl-4-oxo-2-thioxothiazolidinylidene)methyl)-N-(3-carboxy-4-hydroxy)phenyl-2,5-dimethylpyrroles and related derivatives targeting HIV-1 gp41.
    He XY; Lu L; Qiu J; Zou P; Yu F; Jiang XK; Li L; Jiang S; Liu S; Xie L
    Bioorg Med Chem; 2013 Dec; 21(23):7539-48. PubMed ID: 23673219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and evaluation of potential inhibitors of HIV gp120-CD4 interactions.
    Boussard C; Klimkait T; Mahmood N; Pritchard M; Gilbert IH
    Bioorg Med Chem Lett; 2004 May; 14(10):2673-6. PubMed ID: 15109676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific Noncovalent Interactions Determine Optimal Structure of a Buried Ligand Moiety: QM/MM and Pure QM Modeling of Complexes of the Small-Molecule CD4 Mimetics and HIV-1 gp120.
    Moraca F; Rinaldo D; Smith AB; Abrams CF
    ChemMedChem; 2018 Mar; 13(6):627-633. PubMed ID: 29337418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.